Works matching IS 00912700 AND DT 2024 AND VI 64 AND IP 1


Results: 16
    1
    2
    3
    4
    5
    6

    Target Occupancy and Functional Inhibition of JAK3 and TEC Family Kinases by Ritlecitinib in Healthy Adults: An Open‐Label, Phase 1 Study.

    Published in:
    Journal of Clinical Pharmacology, 2024, v. 64, n. 1, p. 67, doi. 10.1002/jcph.2347
    By:
    • Martin, David A.;
    • Telliez, Jean‐Baptiste;
    • Pleasic‐Williams, Susan;
    • Zhang, Ying;
    • Tierney, Brendan;
    • Blatnik, Matthew;
    • Gale, Jeremy D.;
    • Banfield, Chris;
    • Zhou, Yifan;
    • Lejeune, Alexandre;
    • Zwillich, Samuel H.;
    • Stevens, Erin;
    • Tiwari, Neeraj;
    • Kieras, Elizabeth;
    • Karanam, Ashwin
    Publication type:
    Article
    7
    8
    9
    10
    11

    Drug‐Related Adverse Reactions in Pediatric Inflammatory Bowel Disease.

    Published in:
    Journal of Clinical Pharmacology, 2024, v. 64, n. 1, p. 103, doi. 10.1002/jcph.2339
    By:
    • Losa, Ana;
    • Gomes, Rita;
    • Mourão, Francisco Ribeiro;
    • Cardoso, Sandra Soares;
    • Vieira, Paula Manuel;
    • Correia, Mário Rui;
    • Silva, Helena Moreira;
    • Silva, Gisela;
    • Tavares, Marta;
    • Silva, Ermelinda Santos;
    • Lima, Rosa
    Publication type:
    Article
    12
    13
    14
    15
    16

    Issue Information.

    Published in:
    Journal of Clinical Pharmacology, 2024, v. 64, n. 1, p. 1, doi. 10.1002/jcph.2075
    Publication type:
    Article